A Cooley team advised Hengrui Pharma, an innovative, global pharmaceutical company dedicated to the research, development and commercialization of high-quality medicines to address unmet clinical needs, on its global strategic collaboration and license agreements with Bristol Myers Squibb to advance a portfolio of 13 early stage programs in oncology, hematology and immunology, with the goal of accelerating discovery and development of innovative medicines for the benefit of patients worldwide. Congratulations to Hengrui and to the Cooley team led by Lila Hope, Jennifer Raab, Jiqiang Lin, Freddy Yip, PhD and Yuhan Wu. ➡️ Read more here: https://bit.ly/4eJFW26
About us
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation. Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people. Attorney Advertising: This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you and Cooley LLP, Cooley (UK) LLP, Cooley SG LLP, Cooley HK or any other Cooley entity (collectively referred to as “Cooley”). By reviewing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice, and it is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. This content may be considered attorney advertising. Do not send any confidential information to Cooley, as we do not have any duty to keep it confidential. Cooley’s privacy policy: https://bit.ly/CooleyLLPprivacy
- Website
-
http://www.cooley.com
External link for Cooley LLP
- Industry
- Law Practice
- Company size
- 1,001-5,000 employees
- Headquarters
- Palo Alto, CA
- Type
- Partnership
- Founded
- 1920
- Specialties
- law firm, venture capital, private equity, legal advice, going private, incorporation, litigation, technology, life sciences, clean tech, licensing, patent, litigation, trademark, employment, bankruptcy, restructuring, and ESOP
Locations
-
Primary
Get directions
3175 Hanover Street
Palo Alto, CA 94304, US
Employees at Cooley LLP
Updates
-
Huge cheers to the San Diego team for giving back alongside the Frosted Faces Foundation last week, taking a group of senior dogs out for a sunny morning hike. There’s nothing better than combining community impact with some time spent with furry friends!
-
-
-
-
-
+1
-
-
Cooley advised Avantia Law, an AI-native law firm built for the pace and complexity of private markets, on its acquisition by Carta, one of the leading fund administration and fund operations platforms serving institutional asset managers globally. Congratulations to Avantia and to the Cooley team led by Ben Shribman, Harry Calkin and Aaron Archer, with support from Maddie Drabble, Paula Holland, Jack Jones, Eerik Kukebal, Amy Collins, Amber Fisher, Christopher Stack, Kafeel Azher and Nikki Taylor. ➡️ Read more here: https://bit.ly/42AXg1R
-
-
Kudos to Team Cooley on being shortlisted for Legal Business’ Global London Law Firm of the Year award. We look forward celebrating the nod during the awards ceremony in September in London. Learn more: https://bit.ly/4udmv6G
-
-
A Cooley team – led by Eric Blanchard, Evan Leitner, Richard Segal, Divakar Gupta, Trevor Bossi, Brenna McGuire, Chelsea Braun and Amelia Griffiths – advised the underwriters of Odyssey Therapeutics, a clinical-stage biopharmaceutical company developing medicines that are designed to precisely target disease pathology, in connection with Odyssey’s $279 million upsized initial public offering (IPO) and concurrent $25 million private placement. Congratulations, all. 👉 Read more here: https://bit.ly/4djrlaW
-
-
A Cooley team – led by Kevin K. Rooney and Michael Perretta – advised Kalshi, the world’s largest prediction market where people can trade on real-world events, on its $1 billion Series F round at a $22 billion valuation, led by Coatue, with participation from Sequoia Capital, Andreessen Horowitz, IVP, Paradigm, Morgan Stanley and ARK Invest. Congratulations, all. ➡️ Read more here: https://bit.ly/4uDPUq6
-
-
Join Cooley on May 21 for a virtual series exploring some of the most pressing legal topics in the gaming industry today. Hear from our panelists – Michelle Rogers, Rebekah Donaleski, Brian Nelson, Teresa Harrold Michaud, CIPP and Elizabeth Prelogar – about the regulatory environment facing companies entering this industry, what the forthcoming decisions may mean for other existing online gambling and sports-betting platforms, and how the issue may be approached if – and when – it reaches the US Supreme Court. 📆 Register here: https://bit.ly/4nqOa1h
-
-
Cooley advised OpenAI on the formation of OpenAI Deployment Company, a private-equity backed joint venture designed to help organizations build and deploy AI systems they can rely on every day across their most important work. Ben Beerle, Amelia Davis, TJ Graham, Eileen Marshall, Stephanie Gentile, Scott McCall, Katie Rosati, Seamus Howard, David H. Z., Calvin Lee and Mark Cornillez-Ty led the Cooley team advising OpenAI on the formation of this joint venture. In connection with the OpenAI Deployment Company’s launch, Cooley also advised OpenAI on its agreement to acquire Tomoro, an applied AI consulting and engineering firm that helps enterprises turn AI into operational advantage. Ben Shribman, Ben Beerle, Laurence Nelson, Arabella Murrison, David Wilson, Jack Jones, Ondrej Hajda, Paula Holland, Bethan Chalmers, Kafeel Azher, Christopher Stack, Chris Coulter, Leo Spicer-Phelps, Amber Fisher, Olivia Anderson and Eerik Kukebal led the Cooley team advising OpenAI on this acquisition. Read more: https://bit.ly/4nmPfai
-
-
Having a competitive analysis of your technology can give you an edge in conversations with buyers, according to Cooley partner Jamie Leigh during our recent Market Talks webinar on the evolving AI landscape. 🎥 Get the full webinar replay here: https://bit.ly/4uCDS0o
-
A Cooley team advised Knight-Swift Transportation (NYSE: KNX), one of North America’s largest and most diversified freight transportation companies, on its upsized $1.5 billion aggregate principal amount of 1% convertible senior notes due 2031 in a private placement only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, which includes full exercise of the initial purchasers’ option to purchase up to an additional $200 million aggregate principal amount of the notes. Congratulations to Knight-Swift and to the Cooley team led by Jason Savich, Logan Tiari, John-Paul Motley, Ellie Seber and Mischi aMarca. 👉 Read more here: https://bit.ly/3PC1bZj
-